Melkorka Maggadottir

  • PhD student; MD

HELSE SØR-ØST

Education:

2017-to date: PhD student at the Department of Cellular Therapy/Faculty of Medicine University of Oslo, Norway.

2011-2014: Board Certified Allergist and Immunologist, University of Pennsylvania (UPENN), PA, USA. ”

2008-2011: Board Certified Pediatrician, University of Connecticut, Hartford, CT, USA.

1999-2005: MD, University of Iceland, Reykjavik, Iceland.

 

Research interests/projects:

Development and clinical implementation of novel immunotherapies

    • Translation/transition of pre-clinical data into clinical trials with focus on safety and efficacy
    • Therapeutic TCR (T Cell Receptor) discovery, validation and translation into clinical trials
    • Therapeutic CAR (Chimeric Antigen Receptor) discovery, validation and translation into clinical trials
    • Improvement and advancement of clinical trials in cell-based therapy

Work experience

2017-to date:   PhD student, Department of Cellular Therapy, OUS-Radiumhospitalet, Norway

2014-2016:     Immunology Specialist MD at the Department of Immunology, LSH University Hospital, Iceland.

2011-2014:     Fellowship in Allergy/Immunology, The Children’s Hospital of Philadelphia, PA, USA

2008-2011:     Pediatric Internship/Residency, Connecticut Children’s Medical Center, CT, USA 

2006-2008:     Critical Care/Anesthesiology and Pediatric Resident, LSH University Hospital, Iceland

2005-2006:     Rotating Internship in Medicine, Surgery and Pediatrics, Landspitali (LSH) University Hospital, Iceland

Awards

  • Oral presentation at AAAAI was selected as one of 9 abstracts from >1000 abstracts to be discussed at one of three press events during the meeting.
  • Travel awards from AAAAI: 2011, 2013 and 2014. ACAAI: 2012 and 2013. ESID: 2012 and CIS: 2014.
  • “Outstanding intern award” in pediatric residency in Connecticut, 2009.
  • “Best research project of the year” in medical school, 2003.
 
Page visits: 1286